Parkman Healthcare Partners LLC - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q2 2023$4,113,986
+42.6%
216,868
+16.6%
0.71%
+13.5%
Q1 2023$2,885,558
+2.9%
186,045
+17.7%
0.63%
-15.9%
Q4 2022$2,804,607
-0.1%
158,006
+160.0%
0.75%
+3.9%
Q4 2020$2,807,000
-46.9%
60,781
-59.5%
0.72%
-48.6%
Q3 2020$5,284,000
+73.4%
150,151
+20.0%
1.40%
+63.1%
Q2 2020$3,047,000
+387.5%
125,125
+211.8%
0.86%
+195.9%
Q1 2020$625,00040,1250.29%
Other shareholders
IMMUNOVANT INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 3,000,200$26,072,0005.92%
MANGROVE PARTNERS IM, LLC 1,139,900$9,906,0000.89%
Eventide Asset Management 4,950,000$43,016,0000.57%
Ghost Tree Capital, LLC 200,000$1,738,0000.51%
WITTENBERG INVESTMENT MANAGEMENT, INC. 140,500$1,221,0000.47%
FRAZIER MANAGEMENT LLC 585,759$5,090,0000.41%
MANGROVE PARTNERS IM, LLC 500,000$4,345,0000.39%
EcoR1 Capital, LLC 1,140,819$9,914,0000.34%
BCK CAPITAL MANAGEMENT LP 53,459$465,0000.28%
PLATINUM INVESTMENT MANAGEMENT LTD 555,065$4,824,0000.14%
View complete list of IMMUNOVANT INC shareholders